IDH1 and acute myeloid leukemia: Apart from AML, IDH1 mutations are also seen in more than 70% of glioblastomas [6], more than 55% of chondrosarcomas [10], about 13% of intrahepatic cholangiocarcinomas [11], and about 10% of malignant melanomas [12].